Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma SA Spain
Original Assignee
Instituto de Farmacologia Espanola SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto de Farmacologia Espanola SLfiledCriticalInstituto de Farmacologia Espanola SL
Priority to ES380035ApriorityCriticalpatent/ES380035A2/en
Publication of ES380035A2publicationCriticalpatent/ES380035A2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Improvements introduced in the object of patent no. 364,070, by "procedure for obtaining water-soluble tetracycline salts", characterized by placing pyrrolidin-methyl-oxytetracycline or 4-hydroxyethyl-piperazine-methyl-oxytetracycline in the presence of guaiac-glycolic acid . (Machine-translation by Google Translate, not legally binding)
ES380035A1970-05-251970-05-25Procedure for obtaining hydrosoluble tetracycline salts. (Machine-translation by Google Translate, not legally binding)
ExpiredES380035A2
(en)
Procedure for the preparation of stable injectable solutions containing salts of 1-lower-2-piridinoaldoxima. (Machine-translation by Google Translate, not legally binding)